Thus, the autophagosome formation inhibition-mediated activation of AIM2 inflammasome can also synergize with a molecular-targeted drug, FLT3 inhibitor, to induce irreversible differentiation in leukemia cells with FLT3-ITD even in the presence of FGF2. Here, FLT3 is linked to leukemia.